Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 COVID-19 impact analysis at global level
1.7 Data sources
1.7.1 Secondary
1.7.1.1 Paid sources
1.7.1.2 Unpaid sources
1.7.2 Primary
Chapter 2 Executive Summary
2.1 Tissue diagnostics industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Technology trends
2.1.5 Application trends
2.1.6 End-use trends
Chapter 3 Tissue Diagnostics Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of cancer globally
3.2.1.2 Growth of personalized therapeutics and diagnostics
3.2.1.3 Growing demand for digital pathology
3.2.1.4 Increasing number of private diagnostic centers globally
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of skilled professionals
3.2.2.2 High cost of diagnosis and reimbursement issues
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By technology
3.3.3 By application
3.3.4 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Technology landscape
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive landscape
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive dashboard
4.4 Company market share, 2022
4.5 Competitive analysis of major market players
4.6 Competitive positioning matrix
4.7 Strategic outlook matrix
Chapter 5 Tissue Diagnostics Market and Forecast, By Product (USD Million)
5.1 Key trends, by product
5.2 Consumables
5.2.1 Kits
5.2.2 Reagents
5.2.3 Antibodies
5.2.4 Probes
5.3 Instruments
5.3.1 Scanners
5.3.2 Tissue Processing Systems
5.3.3 Slide staining systems
5.3.4 Others
Chapter 6 Tissue Diagnostics Market and Forecast, By Technology (USD Million)
6.1 Key trends, by technology
6.2 Immunohistochemistry (IHC)
6.3 In-situ hybridization (ISH)
6.4 Special staining
6.5 Digital pathology
6.6 Management
Chapter 7 Tissue Diagnostics Market Size and Forecast, By Application (USD Million)
7.1 Key trends, by application
7.2 Breast cancer
7.3 Prostate cancer
7.4 Lung cancer
7.5 Lymphoma
7.6 Gastric cancer
7.7 Others
Chapter 8 Tissue Diagnostics Market Size and Forecast, By End-use (USD Million)
8.1 Key trends, by end-use
8.2 Hospitals
8.3 Research laboratories
8.4 Pharmaceutical companies
8.5 CROs
8.6 Others
Chapter 9 Tissue diagnostics Market and Forecast, By Region (USD Million)
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Switzerland
9.3.8 Norway
9.3.9 Finland
9.3.10 Sweden
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Taiwan
9.4.7 Indonesia
9.4.8 Vietnam
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Colombia
9.5.5 Chile
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Israel
Chapter 10 Company Profiles
10.1 F. Hoffmann-La Roche Ltd.
10.2 Abbott Laboratories
10.3 Siemens
10.4 Danaher
10.5 bioMérieux SA
10.6 QIAGEN
10.7 Becton Dickinson & Company
10.8 Merck KGaA
10.9 Thermo Fisher Scientific, Inc.
10.10 Agilent Technologies, Inc
10.11 GE Healthcare
10.12 BioGenex
10.13 Cell Signaling Technology, Inc.
